✦ LIBER ✦

Neuroprotection in Parkinson’s disease; a commentary

✍ Scribed by Emilia Mabel Gatto; Natalia Riobó; María Cecilia Carreras; Juan José Poderoso; Federico E. Micheli

Book ID: 111737020
Publisher: Springer-Verlag
Year: 2002
Tongue: English
Weight: 447 KB
Volume: 4
Category: Article
ISSN: 1029-8428
DOI: 10.1080/10298420290015881

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroprotection in idiopathic Parkinson'

Neuroprotection in idiopathic Parkinson's disease

✍ Heinz Reichmann 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 146 KB

Progress in neuroprotection in Parkinson

Progress in neuroprotection in Parkinson’s disease

✍ A. H. V. Schapira 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Designing neuroprotection trials in Park

Designing neuroprotection trials in Parkinson's disease

✍ Karl Kieburtz 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

Neuroprotection in Parkinson's disease:

Neuroprotection in Parkinson's disease: Clinical trials

✍ Fabrizio Stocchi; C. Warren Olanow 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

Bioenergetic approaches for neuroprotect

Bioenergetic approaches for neuroprotection in Parkinson's disease

✍ M. Flint Beal 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Neuroprotection trials in Parkinson's di

Neuroprotection trials in Parkinson's disease: Systematic review

✍ Robert G. Hart; Lesly A. Pearce; Bernard M. Ravina; Toby C. Yaltho; John R. Marl 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract Treatments to slow the progression are a major unmet need in Parkinson's disease. Detailed assessment of randomized trials testing putative neuroprotective drugs was undertaken to inform the design, reporting, and interpretation of future studies. This study is a systematic review of tr